Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

The assessment of serum drug levels to diagnose non-adherence in stable chronic heart failure patients

R. Pelouch, V. Voříšek, V. Furmanová, M. Solař

. 2019 ; 62 (2) : 52-57. [pub] 20190423

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články, pozorovací studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc20005515

Grantová podpora
PRVOUK 037/03 Univerzita Karlova v Praze

BACKGROUND: The aim of our study was to evaluate the prevalence of drug non-adherence in stable chronic heart failure (CHF) patients using serum drug levels (SDL) assessment. METHODS: CHF patients were prospectively enrolled during scheduled outpatient visit. Except standard procedures an unanticipated blood sampling for the SDL assessment was obtained. Analysis was focused on the prescribed heart failure and antihypertensive medication and was performed by liquid chromatography coupled with mass spectrometry. The patient was labelled as non-adherent if at least one of drugs assessed was not found in the serum. In the first half of patients multiple SDL have been evaluated during the follow-up. RESULTS: Eighty one patients were enrolled. The non-adherence was proven in twenty of them (25%). In the subgroup of thirty eight patients with multiple SDL evaluation the non-adherence raised significantly with increasing number of visits assessed together (21% for single visit, 29% for two of three visits assessed together and 34% for all three visits evaluated together, all p < 0.001). CONCLUSION: The non-adherence was proven in significant part of stable CHF patients using SDL assessment. This method seems to be reliable and effective and should be a part of clinical assessment in selected patients with CHF.

Citace poskytuje Crossref.org

Bibliografie atd.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc20005515
003      
CZ-PrNML
005      
20200610103119.0
007      
ta
008      
200511s2019 xr d f 000 0|eng||
009      
AR
024    7_
$a 10.14712/18059694.2019.46 $2 doi
035    __
$a (PubMed)31012842
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Pelouch, Radek $7 xx0123186 $u Department of Internal Medicine, Faculty of Medicine in Hradec Králové, Charles University, Hradec Králové, Czech Republic; 1st Department of Internal Medicine - Cardioangiology, University Hospital Hradec Králové, Czech Republic
245    14
$a The assessment of serum drug levels to diagnose non-adherence in stable chronic heart failure patients / $c R. Pelouch, V. Voříšek, V. Furmanová, M. Solař
504    __
$a Literatura
520    9_
$a BACKGROUND: The aim of our study was to evaluate the prevalence of drug non-adherence in stable chronic heart failure (CHF) patients using serum drug levels (SDL) assessment. METHODS: CHF patients were prospectively enrolled during scheduled outpatient visit. Except standard procedures an unanticipated blood sampling for the SDL assessment was obtained. Analysis was focused on the prescribed heart failure and antihypertensive medication and was performed by liquid chromatography coupled with mass spectrometry. The patient was labelled as non-adherent if at least one of drugs assessed was not found in the serum. In the first half of patients multiple SDL have been evaluated during the follow-up. RESULTS: Eighty one patients were enrolled. The non-adherence was proven in twenty of them (25%). In the subgroup of thirty eight patients with multiple SDL evaluation the non-adherence raised significantly with increasing number of visits assessed together (21% for single visit, 29% for two of three visits assessed together and 34% for all three visits evaluated together, all p < 0.001). CONCLUSION: The non-adherence was proven in significant part of stable CHF patients using SDL assessment. This method seems to be reliable and effective and should be a part of clinical assessment in selected patients with CHF.
650    _2
$a senioři $7 D000368
650    _2
$a antihypertenziva $x krev $x terapeutické užití $7 D000959
650    _2
$a kardiotonika $x krev $x terapeutické užití $7 D002316
650    _2
$a chromatografie kapalinová $7 D002853
650    12
$a chronická nemoc $x psychologie $7 D002908
650    _2
$a srdeční selhání $x farmakoterapie $7 D006333
650    _2
$a lidé $7 D006801
650    _2
$a hmotnostní spektrometrie $7 D013058
650    _2
$a adherence k farmakoterapii $x psychologie $x statistika a číselné údaje $7 D055118
650    _2
$a lidé středního věku $7 D008875
655    _2
$a časopisecké články $7 D016428
655    _2
$a pozorovací studie $7 D064888
700    1_
$a Voříšek, Viktor $7 xx0062745 $u Institute of Clinical Biochemistry and Diagnostics, University Hospital Hradec Králové, Czech Republic
700    1_
$a Furmanová, Věra $7 _AN103657 $u Institute of Clinical Biochemistry and Diagnostics, University Hospital Hradec Králové, Czech Republic
700    1_
$a Solař, Miroslav $7 xx0057873 $u Department of Internal Medicine, Faculty of Medicine in Hradec Králové, Charles University, Hradec Králové, Czech Republic; 1st Department of Internal Medicine - Cardioangiology, University Hospital Hradec Králové, Czech Republic
773    0_
$w MED00010947 $t Acta Medica (Hradec Kralove) $x 1805-9694 $g Roč. 62, č. 2 (2019), s. 52-57
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31012842 $y Pubmed
856    41
$u https://actamedica.lfhk.cuni.cz/media/pdf/18059694.2019.46.pdf $y plný text volně přístupný
910    __
$a ABA008 $b A 3077 $c 1072 $y p $z 0
990    __
$a 20200511 $b ABA008
991    __
$a 20200610103115 $b ABA008
999    __
$a ok $b bmc $g 1530850 $s 1095570
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 62 $c 2 $d 52-57 $e 20190423 $i 1805-9694 $m Acta Medica $n Acta Med. (Hradec Král.) $x MED00010947
GRA    __
$a PRVOUK 037/03 $p Univerzita Karlova v Praze
LZP    __
$b NLK118 $a Pubmed-20200511

Najít záznam

Citační ukazatele

Možnosti archivace